RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression

被引:16
作者
Wang, Yanyan [1 ,2 ,3 ]
Tai, Yun-Ling [1 ]
Way, Grayson [1 ,4 ]
Zeng, Jing [1 ]
Zhao, Derrick [1 ,2 ]
Su, Lianyong [1 ,2 ]
Jiang, Xixian [1 ,2 ]
Jackson, Kaitlyn G. [1 ,2 ]
Wang, Xuan [1 ,2 ]
Gurley, Emily C. [1 ,2 ]
Liu, Jinze [5 ]
Liu, Jinpeng [6 ]
Chen, Weidong [3 ]
Wang, Xiang-Yang [2 ,7 ,8 ,9 ]
Sanyal, Arun J. [10 ]
Hylemon, Phillip B. [1 ,2 ]
Zhou, Huiping [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, 1220 East Broad St,MMRB 5044, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA
[3] Anhui Univ Chinese Med, Sch Pharmaceut Sci, Hefei, Peoples R China
[4] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA 23298 USA
[5] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA
[6] Univ Kentucky, Dept Comp Sci, Lexington, KY USA
[7] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA USA
[8] Virginia Commonwealth Univ, Inst Mol Med, Sch Med, Richmond, VA USA
[9] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA USA
[10] Virginia Commonwealth Univ, Dept Internal Med GI Div, Sch Med, Richmond, VA USA
基金
美国国家卫生研究院;
关键词
Bile acids; NASH; Inflammation; Sphingosine kinase; Sphingosine-1 phosphate receptor 2; NEUTROPHIL EXTRACELLULAR TRAPS; SPHINGOSINE KINASE 2; HEPATIC STEATOSIS; LIVER; RESISTANCE; ACTIVATION; FIBROSIS;
D O I
10.1186/s13578-022-00910-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background NAFLD has become the most common chronic liver disease worldwide. Human antigen R (HuR), an RNA-binding protein, is an important post-transcriptional regulator. HuR has been reported as a key player in regulating lipid homeostasis in the liver and adipose tissues by using tissue-specific HuR knockout mice. However, the underlying mechanism by which hepatocyte-specific HuR regulates hepatic lipid metabolism under metabolic stress remains unclear and is the focus of this study. Methods Hepatocyte-specific HuR deficient mice (HuR(hKO)) and age-/gender-matched control mice, as well as long-noncoding RNA H19 knockout mice (H19(-/-)), were fed a Western Diet plus sugar water (WDSW). Hepatic lipid accumulation, inflammation and fibrosis were examined by histology, RNA transcriptome analysis, qRT-PCR, and Western blot analysis. Bile acid composition was measured using LC-MS/MS. Results Hepatocyte-specific deletion of HuR not only significantly increased hepatic lipid accumulation by modulating fatty acid synthesis and metabolism but also markedly induced inflammation by increasing immune cell infiltration and neutrophil activation under metabolic stress. In addition, hepatic deficiency of HuR disrupted bile acid homeostasis and enhanced liver fibrosis. Mechanistically, HuR is a repressor of H19 expression. Analysis of a recently published dataset (GSE143358) identified H19 as the top-upregulated gene in liver-specific HuR knockout mice. Similarly, hepatocyte-specific deficiency of HuR dramatically induced the expression of H19 and sphingosine-1 phosphate receptor 2 (S1PR2), but reduced the expression of sphingosine kinase 2 (SphK2). WDSW-induced hepatic lipid accumulation was alleviated in H19(-/-) mice. Furthermore, the downregulation of H19 alleviated WDSW-induced NAFLD in HuR(hKO) mice. Conclusions HuR not only functions as an RNA binding protein to modulate post-transcriptional gene expression but also regulates H19 promoter activity. Hepatic HuR is an important regulator of hepatic lipid metabolism via modulating H19 expression.
引用
收藏
页数:18
相关论文
共 51 条
[1]   Current and Potential Therapies Targeting Inflammation in NASH [J].
Albhaisi, Somaya ;
Noureddin, Mazen .
FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[2]   NAFLD: A multisystem disease [J].
Byrne, Christopher D. ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2015, 62 :S47-S64
[3]   Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223 [J].
Calvente, Carolina Jimenez ;
Tameda, Masahiko ;
Johnson, Casey D. ;
del Pilar, Hana ;
Lin, Vun Chin ;
Adronikou, Nektaria ;
Du Jeu, Xavier De Mollerat ;
Llorente, Cristina ;
Boyer, Josh ;
Feldstein, Ariel E. .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10) :4091-4109
[4]  
Cariou B., 2021, DIABETES OBES METAB, DOI [10.1111/dom.1432, DOI 10.1111/DOM.1432]
[5]   Two Faces of Neutrophils in Liver Disease Development and Progression [J].
Cho, Yeonhee ;
Szabo, Gyongyi .
HEPATOLOGY, 2021, 74 (01) :503-512
[6]   Nonalcoholic Fatty Liver Disease 2020: The State of the Disease [J].
Cotter, Thomas G. ;
Rinella, Mary .
GASTROENTEROLOGY, 2020, 158 (07) :1851-1864
[7]   Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid [J].
de Boer, Jan Freark ;
de Vries, Hilde D. ;
Palmiotti, Anna ;
Li, Rumei ;
Doestzada, Marwah ;
Hoogerland, Joanne A. ;
Fu, Jingyuan ;
La Rose, Anouk M. ;
Westerterp, Marit ;
Mulder, Niels L. ;
Hovingh, Milaine, V ;
Koehorst, Martijn ;
Kloosterhuis, Niels J. ;
Wolters, Justina C. ;
Bloks, Vincent W. ;
Haas, Joel T. ;
Dombrowicz, David ;
Staels, Bart ;
van de Sluis, Bart ;
Kuipers, Folkert .
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 11 (04) :1045-1069
[8]   Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis [J].
Dulai, Parambir S. ;
Singh, Siddharth ;
Patel, Janki ;
Soni, Meera ;
Prokop, Larry J. ;
Younossi, Zobair ;
Sebastiani, Giada ;
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Stal, Per ;
Wong, Vincent Wai-Sun ;
Kechagias, Stergios ;
Hultcrantz, Rolf ;
Loomba, Rohit .
HEPATOLOGY, 2017, 65 (05) :1557-1565
[10]   Mechanisms of NAFLD development and therapeutic strategies [J].
Friedman, Scott L. ;
Neuschwander-Tetri, Brent A. ;
Rinella, Mary ;
Sanyal, Arun J. .
NATURE MEDICINE, 2018, 24 (07) :908-922